Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease.
Saved in:
| Title: | Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease. |
|---|---|
| Authors: | Patrick GJ; Department of Dermatology and., Liu H; Department of Dermatology and., Alphonse MP; Department of Dermatology and., Dikeman DA; Department of Dermatology and., Youn C; Department of Dermatology and., Otterson JC; Department of Dermatology and., Wang Y; Department of Dermatology and., Ravipati A; Department of Dermatology and., Mazhar M; Department of Dermatology and., Denny G; Department of Dermatology and., Ortines RV; Department of Dermatology and., Zhang E; Department of Dermatology and., Miller RJ; Department of Dermatology and., Dillen CA; Department of Dermatology and., Liu Q; Department of Dermatology and., Nolan SJ; Department of Dermatology and., Nguyen K; Department of Dermatology and., Marcello L; Department of Dermatology and., Do DC; Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Wier EM; Department of Dermatology and., Zhang Y; Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Caviness G; Immunology & Respiratory Diseases Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA., Klimowicz AC; Immunology & Respiratory Diseases Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA., Mierz DV; Immunology & Respiratory Diseases Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA., Fine JS; Immunology & Respiratory Diseases Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA., Sun G; Laboratory of Allergic Diseases, NIAID, NIH, Bethesda, Maryland, USA., Goldbach-Mansky R; Translational Autoinflammatory Disease Section (TADS), NIAID, NIH, Bethesda, Maryland, USA., Marusina AI; Department of Dermatology, School of Medicine, University of California, Davis, Sacramento, California, USA., Merleev AA; Department of Dermatology, School of Medicine, University of California, Davis, Sacramento, California, USA., Maverakis E; Department of Dermatology, School of Medicine, University of California, Davis, Sacramento, California, USA., Garza LA; Department of Dermatology and., Milner JD; Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA., Gao P; Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Ramanujam M; Immunology & Respiratory Diseases Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA., Raymond EL; Immunology & Respiratory Diseases Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA., Archer NK; Department of Dermatology and., Miller LS; Department of Dermatology and. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2021 Mar 01; Vol. 131 (5). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
